After validation of TZM–HER2 FLIM-FRET in vitro, we tested whether TZM–HER2 binding could be detected in vivo using MFLI-FRET imaging of nude mice bearing AU565 tumor xenografts. This evidence concerns the gene ERBB2 and neoplasm.